Skip to main content
JOONGANG ADVANCED MATERIALS Co., Ltd logo

JOONGANG ADVANCED MATERIALS Co., Ltd — Investor Relations & Filings

Ticker · 051980 ISIN · KR7051980001 KO Manufacturing
Open in API
Filings indexed 639 across all filing types
Latest filing 2019-12-09 Board/Management Inform…
Country KR South Korea
Listing KO 051980

About JOONGANG ADVANCED MATERIALS Co., Ltd

http://www.jamaterials.com

JOONGANG ADVANCED MATERIALS Co., Ltd. is a manufacturer engaged in two primary business segments: communications equipment and building materials. The company develops, produces, and markets wired communication equipment and optical components for the telecommunications sector. In its building materials division, it manufactures and distributes a range of PVC products, including windows and doors, as well as ventilation systems. The company's portfolio also includes plastic products, LED lighting, and medical devices.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This is a standard corporate governance disclosure regarding changes to the board of directors. According to the provided definitions, announcements regarding changes in the board of directors fall under the 'Board/Management Information' (MANG) category.
2019-12-09 Korean
불성실공시법인지정(공시번복)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory notice regarding the designation of 'Central Bio' as an 'unfaithful disclosure corporation' (불성실공시법인) due to a disclosure reversal (공시번복) regarding a convertible bond issuance. This is a regulatory announcement concerning compliance and market sanctions, which falls under the general regulatory filing category as it does not fit into specific financial reporting or corporate action categories.
2019-12-09 Korean
주권매매거래정지(불성실공시법인 지정)
Regulatory Filings Classification · 95% confidence The document is a short, formal notice regarding the suspension of stock trading for Central Bio due to being designated as an unfaithful disclosure corporation. It cites specific KOSDAQ market regulations. Since it is a regulatory announcement regarding trading status rather than a financial report, M&A, or dividend notice, it falls under the general regulatory filing category.
2019-12-09 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Central Bio) regarding the adjustment of the conversion price of its convertible bonds (CB). This type of disclosure, which details changes to financial instruments and capital structure, falls under the category of capital and financing updates. It is not a report announcement, but the actual disclosure of the adjustment event.
2019-12-06 Korean
증권발행결과(자율공시)(일반공모 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a public offering/capital increase) by Central Bio. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2019-12-05 Korean
소액공모실적보고서
Capital/Financing Update Classification · 95% confidence The document is a '소액공모실적보고서' (Small-scale Public Offering Performance Report) filed with the Financial Supervisory Service (FSS) in South Korea. It details the results of a capital raise (share issuance), including subscription status, allocation, and the use of proceeds. This falls under the category of capital and financing updates as it reports on the completion of a specific financing activity.
2019-12-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.